Healthpeak Properties has exceeded its analyst consensus target, leaving no positive asymmetry at current levels; while the portfolio demonstrates strong cash conversion and a high financial health score, heavy geographic concentration in San Francisco laboratory space and a dividend whose safety is in question make this a name to reduce rather than add.
Thesis pillars
- Sf Lab Portfolio Concentration↓Deteriorating
- Price Above Analyst Target↑Improving
- Dividend Safety Concern→Stable
- +1 more pillar — see the Why tab for full reasoning
Healthpeak Properties, Inc. (DOC) Stock Analysis
Real Estate · REIT - Healthcare Facilities
Sell if holding. Analyst target reached at $22.29 — A.R:R is negative (-1.9) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Geographic: San Francisco lab portfolio (59.0%).
Healthpeak Properties is a healthcare REIT owning 689 properties across outpatient medical (507 buildings), lab (145 buildings), and senior housing (34 communities) segments in the U.S. Revenue comes from leases to healthcare providers, biotech tenants, and RIDEA-structured... Read more
Sell if holding. Analyst target reached at $22.29 — A.R:R is negative (-1.9) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Geographic: San Francisco lab portfolio (59.0%). Chart setup: No clear chart pattern; technical signals are mixed. Score 5.1/10, moderate confidence.
Passes 5/8 gates (clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: moderate.
Recent developments
updated 2026-07-27Recent Developments — Healthpeak Properties, Inc.
Latest news
- NEWS DOC Maintained by Morgan Stanley -- Price Target Lowered to $18. - GuruFocus — GuruFocus negative
- NEWS Healthpeak Properties (NYSE:DOC) Hits New 1-Year Low Following Analyst Downgrade - MarketBeat — MarketBeat negative
- NEWS Morgan Stanley Cuts Healthpeak Properties (NYSE:DOC) Price Target to $18.00 - MarketBeat — MarketBeat negative
- NEWS Healthpeak Q1 earnings, revenue beat on solid leasing activity (DOC:NYSE) - Seeking Alpha — Seeking Alpha positive
- NEWS Healthpeak Properties Inc. stock outperforms competitors on strong trading day - MarketWatch — MarketWatch positive
Generated 2026-07-30T22:29:13Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- LOWTenantHCA Healthcare7.0%10-K Item 1: 'most significant outpatient medical tenant concentration ... HCA Healthcare, Inc. (HCA)| | 15 | %| | 7 | %'
- HIGHGeographicSan Francisco lab portfolio59%10-K Item 1: 'including San Francisco, California (59%), Boston, Massachusetts (22%), and San Diego, California (17%) (based on total square feet)'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Momentum below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Analyst target reached at $22.29 — A.R:R is negative (-1.9) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Geographic: San Francisco lab portfolio (59.0%). Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $21.43. Score 5.1/10, moderate confidence.
Take-profit target: $22.31 (-9.7% upside). Prior stop was $21.43. Stop-loss: $21.43.
Concentration risk — Geographic: San Francisco lab portfolio (59.0%); Analyst target reached - limited upside remaining; Near 52-week high (2.2% away).
Healthpeak Properties, Inc. trades at a P/E of 69.6 (forward -148.5). TrendMatrix value score: 4.6/10. Verdict: Sell.
24 analysts cover DOC with a consensus score of 3.6/5. Average price target: $22.
What does Healthpeak Properties, Inc. do?Healthpeak Properties is a healthcare REIT owning 689 properties across outpatient medical (507 buildings), lab (145...
Healthpeak Properties is a healthcare REIT owning 689 properties across outpatient medical (507 buildings), lab (145 buildings), and senior housing (34 communities) segments in the U.S. Revenue comes from leases to healthcare providers, biotech tenants, and RIDEA-structured senior housing operators; 2025 Adjusted NOI: outpatient medical $796M, lab $567M, senior housing $177M.